Patents by Inventor Deborah L. Novicki

Deborah L. Novicki has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9370570
    Abstract: When using squalene in a vaccine adjuvant, there is a possibility of contamination with polychlorinated biphenyls (PCBs). Environmental exposure to PCBs may adversely affect children's immune responses to routine vaccinations. Thus the invention uses squalene with low or no PCB contamination, particularly when derived from shark liver.
    Type: Grant
    Filed: December 10, 2013
    Date of Patent: June 21, 2016
    Assignee: Novartis AG
    Inventor: Deborah L. Novicki
  • Publication number: 20140170174
    Abstract: When using squalene in a vaccine adjuvant, there is a possibility of contamination with polychlorinated biphenyls (PCBs). Environmental exposure to PCBs may adversely affect children's immune responses to routine vaccinations. Thus the invention uses squalene with low or no PCB contamination, particularly when derived from shark liver.
    Type: Application
    Filed: December 10, 2013
    Publication date: June 19, 2014
    Applicant: Novartis AG
    Inventor: Deborah L. Novicki
  • Patent number: 8628786
    Abstract: When using squalene in a vaccine adjuvant, there is a possibility of contamination with polychlorinated biphenyls (PCBs). Environmental exposure to PCBs may adversely affect children's immune responses to routine vaccinations. Thus the invention uses squalene with low or no PCB contamination, particularly when derived from shark liver.
    Type: Grant
    Filed: December 2, 2011
    Date of Patent: January 14, 2014
    Assignee: Novartis AG
    Inventor: Deborah L. Novicki
  • Publication number: 20120195931
    Abstract: When using squalene in a vaccine adjuvant, there is a possibility of contamination with polychlorinated biphenyls (PCBs). Environmental exposure to PCBs may adversely affect children's immune responses to routine vaccinations. Thus the invention uses squalene with low or no PCB contamination, particularly when derived from shark liver.
    Type: Application
    Filed: December 2, 2011
    Publication date: August 2, 2012
    Inventor: Deborah L. Novicki
  • Patent number: 8092813
    Abstract: When using squalene in a vaccine adjuvant, there is a possibility of contamination with polychlorinated biphenyls (PCBs). Environmental exposure to PCBs may adversely affect children's immune responses to routine vaccinations. Thus the invention uses squalene with low or no PCB contamination, particularly when derived from shark liver.
    Type: Grant
    Filed: October 14, 2008
    Date of Patent: January 10, 2012
    Assignee: Novartis AG
    Inventor: Deborah L. Novicki